StockData
Interpace Biosciences, Inc. logo

Interpace Biosciences, Inc. (IDXG) stock

IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)

Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –

Interpace Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Interpace Biosciences's market cap was $138.50M on Oct 19, 2026, against $4.51M a year earlier. Over the last 2 years it ranged from $3.21M to $209.70M, with a median of $7.88M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$138.50M+2442.3%
2025Dec 31, 2025$5.45M-54.1%
2024Dec 31, 2024$11.88M–

More Interpace Biosciences figures

See a number that looks wrong?